An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model

Molecular and Biochemical Parasitology

Volumn 158, Issue 2, 2008, Pages 213-216

  Mikolajczak, Sebastian A ^a   Aly, Ahmed S I ^a   Dumpit, Ronald F ^a   Vaughan, Ashley M ^a   Kappe, Stefan H I ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gene targeting; Homologous recombination; Malaria; Plasmodium

Indexed keywords

RED FLUORESCENT PROTEIN;

ANOPHELES STEPHENSI; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENE TARGETING; HOMOLOGOUS RECOMBINATION; MALARIA; NONHUMAN; PARASITE DEVELOPMENT; PHENOTYPE; PLASMODIUM YOELII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; ANOPHELES; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; GENE DELETION; GENE TARGETING; MALARIA; MICROSCOPY, FLUORESCENCE; PHENOTYPE; PLASMODIUM YOELII; PROTOZOAN PROTEINS; RECOMBINATION, GENETIC;

PLASMODIUM YOELII; RODENTIA;

EID: 39049171069     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2007.12.006     Document Type: Article

References (13)

1. Ménard R., and Janse C. Gene Targeting in Malaria Parasites. Methods: A Companion to Methods in Enzymology-Analysis of Apicomplexan Parasites vol. 13 (1997), Academic Press Inc. pp. 148-157
2. van Dijk M.R., Janse C.J., and Waters A.P. Expression of a Plasmodium gene introduced into subtelomeric regions of Plasmodium berghei chromosomes. Science 271 (1996) 662-665
3. Menard R., Sultan A.A., Cortes C., et al. Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature 385 (1997) 336-340
4. Mueller A.K., Labaied M., Kappe S.H., et al. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433 (2005) 164-167
5. Mueller A.K., Camargo N., Kaiser K., et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci USA 102 (2005) 3022-3027
6. Labaied M., Harupa A., Dumpit R.F., et al. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun 75 (2007) 3758-3798
7. van Dijk M.R., Douradinha B., Franke-Fayard B., et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci USA 102 (2005) 12194-12199
8. Douradinha B., van Dijk M.R., Ataide R., et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol 37 (2007) 1511-1519
9. Tarun A.S., Dumpit R.F., Camargo N., et al. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic GAP malaria vaccines is independent of detectable liver stage persistence and is mediated by CD8+T cells. J Infect Dis 196 (2007) 608-616
10. Waters A.P., Thomas A.W., van Dijk M.R., et al. Transfection of Malaria Parasites. Methods: A Companion to Methods in Enzymology-Analysis of Apicomplexan Parasites vol. 13 (1997), Academic Press Inc. pp. 134-147
11. Janse C.J., Ramesar J., and Waters A.P. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc 1 (2006) 346-356
12. Tarun A.S., Baer K., Dumpit R.F., et al. Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol 36 (2006) 1283-1293
13. Ecker A., Moon R., Sinden R.E., et al. Generation of gene targeting constructs for Plasmodium berghei by a PCR-based method amenable to high throughput applications. Mol Biochem Parasitol 145 (2006) 265-268